Purchase Order 75N95A23P00117
Award Date
8/31/23
Potential Completion Date
8/30/24
Potential Value
$6.3K
Federal Agency
National Institute of Neurological Disorders and Stroke
Awardee
Cyprotex US LLC
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
East Watertown, MA 02472, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed price purchase order awards $56,313 to Cyprotex US LLC to provide in vitro absorption, distribution, metabolism, excretion, and toxicity (ADMET) characterization services in support of the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute's (NCI) Developmental Therapeutics Program (DTP). The contractor will evaluate two small molecule drug candidates total across 11 specified in vitro ADMET assays, including metabolic...
This is a firm fixed price purchase order awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Cyprotex US LLC, a foreign-owned for-profit organization, for $152,060.00 to provide testing of small molecule compounds. The work is being performed in Watertown, Massachusetts and aligns with the agency's testing and assessment of potential drug compounds. The original solicitation was competed among small businesses, but the contract was not set aside....
This is a federal contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services (HHS), to Cyprotex US LLC, a leading contract research organization specializing in predictive toxicology and ADME (absorption, distribution, metabolism, and excretion) research. The $18,024.00 firm fixed-price purchase order contract is for the testing of two compounds against key ADME and DMPK (drug metabolism and...
This firm fixed-price purchase order was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Cyprotex US LLC, a foreign-owned for-profit contract research organization. The $157,158 contract is for the characterization of absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of small-molecule drug candidates using standardized in vitro methods. This work supports...
This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to Cyprotex US LLC, a foreign-owned for-profit contract research organization. The $109,392.00 contract is for compound testing services, including plasma protein binding studies, PXR and AhR activation studies, and CYP inhibition assays on various small molecule compounds. This work supports NIDA's mission to seek fundamental...
This is a firm-fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services (HHS), to Cyprotex US LLC, a foreign-owned, for-profit contract research organization. The $80,000 contract is for the provision of testing services for 30 compounds, including conducting cytochrome P450 (CYP) inhibition testing, Caco-2 permeability assays, and other absorption, distribution, metabolism,...
The Department of Health and Human Services' National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $20,446.64 firm fixed price purchase order to Eurofins Discoverx Corporation of Fremont, California. The purchase order is for GPCRMAX PANEL services and will be performed between June 26, 2023 and September 30, 2023 in Fremont. The National Institute of Neurological Disorders and Stroke supports research on brain and nervous system disorders to reduce...
The Department of Health and Human Services' National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $20,446 purchase order to Eurofins Discoverx Corporation of Fremont, California. Under the firm fixed price contract, Eurofins will provide GPCRMAX PANEL services to NIH NINDS from August 2023 through December 2023. As a leading provider of drug discovery services, Eurofins will support NINDS's work to understand, treat, and prevent disorders of the brain...
The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke (HHS-NIH-NINDS) awarded a $2.77 million delivery order to Curia Global Inc., doing business as Amri, under an indefinite-delivery/indefinite-quantity contract for Hit to Lead Chemistry under Performance Area 2. The delivery order is for Medicinal Chemistry Support Program for Therapeutic Development services to be performed in Albany, New York over a three year period...
This firm-fixed-price federal contract was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services (HHS), to Cyprotex US LLC, a foreign-owned, for-profit contract research organization. The $12,295.00 contract is for the provision of specialized testing services to support chemical risk assessment, drug development, and environmental research programs. Cyprotex has a significant Indefinite...